Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography

…, JK Harrison, LL Sanders, TM Bashore, JM Feldman - Circulation, 1995 - Am Heart Assoc
Background Although serotonin has been postulated as an etiologic agent in the development
of carcinoid heart disease, no direct evidence for different ambient serotonin levels in …

Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid

JM Feldman, EM Lee - The American journal of clinical nutrition, 1985 - Elsevier
Using a highly specific radioenzymatic assay we determined the serotonin concentration in
80 types of foods. The following fruits had a high serotonin concentration (mean ± SEM) …

Bronchial carcinoid tumors: a retrospective analysis of 126 patients

DH Harpole, JM Feldman, S Buchanan… - The Annals of thoracic …, 1992 - Elsevier
From 1970 until 1990, 8,958 cases of primary carcinoma of the lung were diagnosed at the
Duke University Medical Center. During the same period, 126 patients (mean age, 53 ± 13 …

The pharmacology of sulfonylureas

TG Skillman, JM Feldman - The American journal of medicine, 1981 - Elsevier
In this report we review the pharmacology of the hypoglycemic sulfonylurea drugs. The
early work with sulfonylureas is briefly described. The pharmacokinetics of first-generation …

Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors

JM Feldman, TM O'dorisio - The American journal of medicine, 1986 - Elsevier
The plasma concentrations of neuropeptides (neurotensin, substance P, motilin, somatostatin,
vasoactive intestinal peptide and gastrin-releasing peptide), the urinary excretion of 5-…

Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma

…, RE Coleman, JP Gockerman, J Moore, JM Feldman… - Surgery, 2003 - Elsevier
INTRODUCTION: Iodine 131–meta-iodobenzylguanidine ( 131 I-MIBG) has been applied to
the palliative treatment of metastatic pheochromocytoma in small studies. We report our …

Gastrointestinal carcinoids: characterization by site of origin and hormone production

…, TZ Hayward, FJ Quayle, JM Feldman… - Annals of …, 2000 - journals.lww.com
Feldman, who is the endocrinologist who kept this database, has also looked at several other
factors, including TNF-α, which … Feldman’s database that we did not include in this study. …

Glyburide: a second‐generation sulfonylurea hypoglycemic agent: history, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects

JM Feldman - … : The Journal of Human Pharmacology and Drug …, 1985 - Wiley Online Library
Glyburide, a second‐generation hypoglycemic sulfonylurea, is 200 times as potent as
tolbutamide. This increase is due to greater intrinsic hypoglycemic potency of the molecule rather …

Detecting pheochromocytoma: defining the most sensitive test

…, S Eubanks, ER Delong, D Oertli, JM Feldman - Annals of …, 2006 - journals.lww.com
Feldman JM. Increased dopamine production in patients with carcinoid tumors. Metabolism.
Feldman JM. Diagnosis and management of pheochromocytoma. Hosp Pract (Off Ed).1989;…

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l-Dopa

…, HE LEBOVITZ, JM FELDMAN - The Journal of Clinical …, 1971 - academic.oup.com
The present study was designed to determine if l-dopa alters endocrine function in humans.
Patients with Parkinson's disease underwent control studies that included determination of …